Summary:
The ARISE Study is designed to assess the safety and effectiveness of an investigational medication for schizophrenia compared to, and also in combination with, your current treatment options. We recognize the unmet need for new treatment options that may help manage symptoms of this complex disorder. Currently, this study is enrolling for an investigational drug that may help those seeking a potential alternative to their current treatment.
Individuals may qualify for the study if they:
- Are 18 to 55 years old
- Have been diagnosed with schizophrenia
- Have a caregiver or person they trust to assist with study activities as needed
- Meet additional health and study critera
Qualified Participants May Receive:
Reimbursement for reasonable, out-of-pocket expenses for travel and accomodations may be available to qualified individuals.